Hannah Timmins

10PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesPredictive and prognostic markersChemotherapyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
Multifactorial Contributors to Dose Limiting and Post-Treatment Neurologic Toxicity During Chemotherapy Treatment.

|May 01, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Nicole Yeung, Tiffany Li, Hui-Ming Lin

|May 05, 2023
Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia.

Lyndal Henden, Liam G Fearnley, Natalie Grima

|Dec 21, 2022
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials.

Jasmine F Ashhurst, Sicong Tu, Hannah C Timmins

|Dec 06, 2022
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study.

Kosar Hooshmand, David Goldstein, Hannah C Timmins

|Apr 22, 2021
Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences.

Alice Yu, Deborah Street, Rosalie Viney

Pageof 2

Frequent Collaborators

4 joint publications

Susanna B Park

3 joint publications

Matthew C Kiernan

2 joint publications

John B Kwok

2 joint publications

Michael Friedlander